Post-viral Fatigue Syndrome
📧 Sign up to get email alerts when something new happens for Post-viral Fatigue Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Low-dose Naltrexone for Post-COVID Fatigue Syndrome [Phase 2]
Phase 2 clinical trial evaluating low-dose naltrexone for post-viral fatigue syndrome has completed; the snippet does not include results.
-
CLINICAL_TRIALS other · 2026-02-06Clinical Trial Update: Mechanisms of Persistent Fatigue
This clinical trial update notes a study from University Hospital, Akershus investigating mechanisms of persistent fatigue after viral infec…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection [Phase 2]
A Phase 2 clinical trial evaluating RUCONEST for improving neurological symptoms in post-COVID-19 infection has completed.